| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 03/13/2008 | US20080063599 Compounds Which Can Be Used To Diagnose And Monitor Diseases Associated With The Formation Of Amyloid Protein Fibrils |
| 03/13/2008 | US20080063598 chimeric antibodies, fragments, polypeptides and derivatives that preferentially bind tumor associated antigens (AF-20), useful in the treatment and diagnosis of cancers |
| 03/13/2008 | CA2663121A1 Treatment, prevention, and reversal of alcohol-induced brain disease |
| 03/13/2008 | CA2662693A1 Aptamers labelled with gallium-68 |
| 03/13/2008 | CA2662449A1 Compounds and methods for 18f labeled agents |
| 03/13/2008 | CA2662350A1 Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| 03/12/2008 | EP1897889A2 Method of modulating the profileration of medullary thyroid carcinoma cells |
| 03/12/2008 | EP1897590A1 Method for carrying out a magnetic therapy of malignant neoplasms |
| 03/12/2008 | EP1897562A1 Aptamers labelled with Gallium-68 |
| 03/12/2008 | EP1896846A2 Analysis method for determining a functional parameter of an organ using preferably an aqueous 13c methacetin solution |
| 03/12/2008 | EP1896507A2 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 03/12/2008 | EP1896086A1 Hydrazide conjugates as imaging agents |
| 03/12/2008 | EP1896085A1 Peptides whose uptake by cells is controllable |
| 03/12/2008 | EP1292611B1 Glycopeptide carboxy-saccharide derivatives |
| 03/12/2008 | EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 03/12/2008 | CN100374456C Specific human antibodies for selective cancer therapy |
| 03/11/2008 | US7342091 Soluble cyclic analogues of β amyloid peptide |
| 03/11/2008 | US7342018 Urokinase inhibitors and uses thereof |
| 03/11/2008 | US7341722 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment |
| 03/11/2008 | US7341711 Porphyrin compounds and their use in high-field MRI |
| 03/11/2008 | US7341709 Compositions for labeling β-amyloid plaques and neurofibrillary tangles |
| 03/11/2008 | US7341708 Methods for producing pure amino acid chelate complexes, and uses thereof |
| 03/11/2008 | CA2451924C Diagnostic agents for pancreatic exocrine function |
| 03/06/2008 | WO2008028116A2 Method and composition to evaluate cytochrome p450 2c19 isoenzyme activity using a breath test |
| 03/06/2008 | WO2008028000A2 Radioimaging moieties coupled to peptidase-binding moieties for imaging tissues and organs that express peptidases |
| 03/06/2008 | WO2008027995A2 Radio-labeled materials and methods of making and using the same |
| 03/06/2008 | WO2008026040A2 68ga-labeled peptide-based radiopharmaceuticals |
| 03/06/2008 | WO2007149453A9 Methods of making and using rubidium-81-containing compositions |
| 03/06/2008 | WO2007148089A3 Radiolabelling methods |
| 03/06/2008 | WO2007126733A3 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
| 03/06/2008 | US20080058579 Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors |
| 03/06/2008 | US20080056991 Histamine H3 receptor inhibitors; (4-Azepan-1-ylmethyl-phenyl)-(4-isopropyl-piperazin-1-yl)-methanone dihydrochloride for example; allergies, nasal congestion, eating disorders, sleep disorders, neurodegenerative disorders |
| 03/06/2008 | US20080056990 Anilinoquinazolinyl amide derivatives; radiolabels as bioprobes for Positron Emission Tomography and Single Photon Emission Computed Tomography, and as radiopharmaceuticals for radiotherapy; improved solubility, bioavailability, biostability |
| 03/06/2008 | US20080056988 [18f]-furanosylpurine derivatives and uses thereof |
| 03/06/2008 | US20080056987 Inhibitor of Eph receptor kinase; treat angiogenesis, lymphangiogenesis or asculogenesis, disorder of the blood vessels, hyperproliferation of body cells, chronic or acute neurodegenerative disorder; enteral, parenteral and oral administration |
| 03/06/2008 | CA2661979A1 Radioimaging moieties coupled to peptidase-binding moieties for imaging tissues and organs that express peptidases |
| 03/05/2008 | EP1894577A1 Radioactive diagnostic imaging agent |
| 03/05/2008 | EP1893246A2 Stereoselective synthesis of amino acid analogs for tumor imaging |
| 03/05/2008 | EP1893245A2 Radiolabeled-pegylation of ligands for use as imaging agents |
| 03/05/2008 | EP1893244A2 Imaging agents |
| 03/05/2008 | EP1370300A4 Manufacturing process to control particle size |
| 03/05/2008 | EP1207904B1 New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy |
| 03/05/2008 | CN101137398A Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications |
| 03/04/2008 | US7338652 Methods for positron emission imaging with radiolabeled halogenated xanthenes diagnostic agents |
| 03/04/2008 | US7338454 Breath test |
| 02/28/2008 | WO2008024830A2 Radiohaloimatinibs and methods of their synthesis and use in pet imaging of cancers |
| 02/28/2008 | WO2008024829A2 Radiohaloimatinibs and methods of their synthesis and use in pet imaging of cancers |
| 02/28/2008 | WO2008024826A2 Radiohalothymidines and methods of their synthesis and use in pet imaging of cancers |
| 02/28/2008 | WO2008024188A2 Dual variable domain immunoglobulin and uses thereof |
| 02/28/2008 | US20080050810 VARIANTS OF HUMANIZED ANTI-CARCINOMA MAb CC49 |
| 02/28/2008 | US20080050376 Compositions And Uses Thereof For Identifying And Targeting Provasopressin-Expressing Cancer Cells |
| 02/28/2008 | US20080050312 Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents |
| 02/28/2008 | US20080050311 Monoclonal Antibody hPAM4 |
| 02/28/2008 | US20080050309 Compositions of pharmaceuticals for use in low energy neutron therapy |
| 02/27/2008 | EP1418950B1 Solid-phase nucleophilic fluorination |
| 02/27/2008 | EP1404867B1 Oligonucleotide transfection screening method |
| 02/27/2008 | EP1311300B1 Radioligand and binding assay |
| 02/27/2008 | EP1282700B1 Neuronal serine-threonine protein kinase |
| 02/27/2008 | CN101133017A Radioactive halogen-labeled phenyloxyaniline derivatives |
| 02/27/2008 | CN101130555A **TC*N nucleus marked dithiocarbamate complex, preparing method and application of the same |
| 02/27/2008 | CN101130506A Synthesis method of image agent used for diagnosis of progeria dementia |
| 02/27/2008 | CN101130078A Intrathecal administration of rituximab for treatment of central nervous system lymphomas |
| 02/26/2008 | US7335750 Hybrid compositions for intracellular targeting |
| 02/26/2008 | US7335748 RG1 antibodies and uses thereof |
| 02/26/2008 | US7335347 Methods for purifying radiolabelled compounds |
| 02/26/2008 | US7335154 Radiotherapy |
| 02/21/2008 | WO2008022319A2 Catalytic radiofluorination |
| 02/21/2008 | WO2008022285A1 Preparation and utility of opioid analgesics |
| 02/21/2008 | WO2008021322A2 Selective alpha particle-mediated depletion of tumor vasculature with vascular normalization |
| 02/21/2008 | WO2007100777A3 Methods for the treatment of adhd and related disorders |
| 02/21/2008 | US20080044349 Therapeutic and diagnostic applications of perlecan domain I splice variants |
| 02/21/2008 | CA2698124A1 Automated system for formulating radiopharmaceuticals |
| 02/21/2008 | CA2661302A1 Preparation and utility of opioid analgesics |
| 02/20/2008 | EP1889834A1 Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same |
| 02/20/2008 | EP1888125A2 Poly(peptide) as a chelator: methods of manufacture and uses |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP0918872B1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 02/20/2008 | CN101128219A Improved n4 chelating agent conjugate |
| 02/20/2008 | CN101125208A Apatite developer and its positron emitting tomography imaging |
| 02/19/2008 | US7332577 Active antithrombin content ranging from 0.03 to 0.10 mg/g of albumin, and a prekallikrein (PKA) activity that remains below 35 IU/ml over time; to increase blood volume in cardiovascular surgery |
| 02/19/2008 | US7332568 Q3 SPARC deletion mutant and uses thereof |
| 02/19/2008 | US7332149 Diagnosis, therapy of cancer, rheumatoid arthritis, for monitoring therapeutic angiogenesis treatment and destruction of new angiogenic vasculature, imaging tumors, atherosclerosis, restenosis, cardiac ischemia, and myocardial reperfusion injury |
| 02/19/2008 | CA2220008C Composition and method for tumor imaging |
| 02/14/2008 | WO2008019217A2 Stereoregular romp polymers |
| 02/14/2008 | WO2008017944A2 Composition apparatus and method for use in imaging |
| 02/14/2008 | US20080038261 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 02/14/2008 | US20080038195 radiolabeling; neurodegenerative diseases |
| 02/14/2008 | US20080038194 System and Method for Expression Proteomics Based on Isotope Ratio Modification |
| 02/14/2008 | US20080038193 Antibodies for use in targeted and temporary treatment of humans and animals |
| 02/14/2008 | US20080038191 Radiolabeled Compounds And Compositions, Their Precursors And Methods For Their Production |
| 02/14/2008 | US20080038190 Composition apparatus and method for use in imaging |
| 02/14/2008 | US20080038189 RNA interference mediated inhibition of aurorakinase B and its combinations as anticancer therapy |
| 02/14/2008 | CA2660242A1 Radiopharmaceutical to be used in distinction between inflammations and infections in orthopaedic implants |
| 02/13/2008 | EP1885755A2 Anti-cd19 antibody therapy for autoimmune disease |
| 02/13/2008 | EP1885742A1 Compositions for targeting amine oxidases in vivo |
| 02/13/2008 | EP1454137B1 Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations |
| 02/13/2008 | EP1379283B1 Identification of target-specific folding sites in peptides and proteins |
| 02/13/2008 | CN101123996A Compositions and methods for enhancing contrast in imaging |
| 02/13/2008 | CN101121713A Method for preparing 2beta-carbonyl-3beta-(4-chlorobenzo)-8-(2-fluoro[18F]ethyl)demethyltropane by one-step method |
| 02/13/2008 | CN100368805C Analysis method of mercapto amine tropine content |